Medical Cannabis for Epilepsy: CBD Evidence and Doses
CBD is the only cannabis compound with FDA approval for epilepsy. Epidiolex treats Dravet, Lennox-Gastaut, and tuberous sclerosis. THC has no approval.
Medical cannabis may help epilepsy by reducing seizure frequency through compounds like cannabidiol (CBD) and tetrahydrocannabinol (THC). CBD has the strongest evidence, especially for treatment-resistant forms such as Dravet and Lennox-Gastaut syndromes. When buying, prioritize products with lab-tested CBD-to-THC ratios, clear dosing, and third-party test results. Avoid products with unknown potency or synthetic cannabinoids.
Medical Cannabis for Epilepsy: CBD Evidence and Doses
Ratio bands guide your choice. A 20:1 CBD to THC ratio is common for epilepsy, meaning 20 parts CBD to 1 part THC. Higher CBD ratios reduce psychoactivity but may be less effective for some. Start low, go slow. A typical starting dose for CBD is 2.5 mg per kg of body weight per day, split into two doses, but consult a doctor. For THC, doses above 10 mg can increase seizure risk. Look for products in these bands:
best medical cannabis strains for epilepsy
No. CBD can reduce seizure frequency in some people, but it is not a cure. It works best as part of a comprehensive treatment plan.
THC has mixed evidence. Some studies show benefit, but others show increased seizure risk. Use only under medical guidance.
Oral oils and tinctures allow precise dosing. Capsules are also consistent. Avoid smoking due to lung irritation and variable absorption.
Look for a certificate of analysis (COA) from a third-party lab. The COA should list cannabinoid content and contaminant tests.
Buy from licensed dispensaries or trusted online brands that provide COAs. Compare CBD to THC ratios, check for organic certification if possible, and start with small amounts. Keep a seizure diary to track effects. Never stop prescribed medication without your doctor's approval.